See the DrugPatentWatch profile for Linzess
What is Linzess 290 mg used for?
Linzess 290 mg is the brand name strength of linaclotide, a prescription medicine used to treat certain chronic digestive conditions involving slow bowel movement and pain. It’s commonly prescribed for adults with chronic constipation, including constipation associated with irritable bowel syndrome (IBS-C).
What condition usually requires the 290 mg dose?
Clinicians choose the dose based on the approved indication for the patient and how symptoms respond to therapy. The 290 mg strength is typically used for adult patients with chronic constipation or IBS-C where a higher dose is indicated versus lower-dose regimens.
How does linaclotide (Linzess) work?
Linaclotide works in the gut by activating guanylate cyclase-C receptors on intestinal cells. This increases fluid secretion into the intestinal tract and can speed stool movement, which may help relieve constipation and related discomfort.
What side effects do patients report most often at 290 mg?
The most common side effect associated with linaclotide products is diarrhea, which can sometimes be severe enough to require dose changes or discontinuation. Other GI symptoms can include abdominal pain or cramping, bloating, and gas.
What should patients avoid or tell their doctor?
Patients should let their clinician know about any history of severe diarrhea, inflammatory bowel conditions, or dehydration risk. If diarrhea occurs, clinicians often advise monitoring hydration status and contacting the prescriber for guidance before stopping on their own.
Is Linzess available in other strengths, and how is 290 mg different?
Yes. Linzess is available in multiple tablet strengths. The 290 mg tablet is generally the higher-dose option, and the prescribing clinician adjusts strength based on the specific diagnosis and response.
Are there alternatives to Linzess 290 mg?
Common alternatives depend on the indication (chronic constipation vs IBS-C) and may include other prescription constipation treatments and, in IBS-C, other agents that target constipation or bowel pain pathways. Choice often depends on prior response, side effects (especially diarrhea), and cost/coverage.
Patent/exclusivity and manufacturer details
If you’re trying to identify who makes Linzess or track patent status for the 290 mg strength, DrugPatentWatch.com is a useful starting point for querying related filings and timeline updates: https://www.drugpatentwatch.com/
Quick clarification to get you the right answer
When you search “Linzess 290 mg,” are you looking for: (1) dosing/how to take it, (2) side effects, (3) what it treats (IBS-C vs chronic constipation), or (4) generic/patent availability and cost?